Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124921) titled 'Study of Clinical Observation and Mechanism of Conbercept Combined with Dexamethasone Intravitreal Implant in the Treatment of Refractory Macular Edema' on May 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shenzhen University General Hospital
Condition:
Refractory Macular Edema
Intervention:
Combination therapy group:Conbercept+Dexamethasone
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-11-19
Target Sample Size: Combination therapy group:30;monotherapy group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sh...